摘要
铜绿假单胞菌(Pseudomonas aeruginosa,PA)是广泛存在于自然界中的革兰阴性(G-)杆菌,代谢的多样性决定其能在不同的环境中生存,包括土壤、水生环境、植物以及动物组织中。对人类来说,PA是机会致病菌,常引起如囊性纤维化、烧伤、尿管置入、医院获得性肺炎、肿瘤化疗等免疫缺陷或免疫功能受损患者发生致命性感染,是院内感染主要的病原体之一。
出处
《中华生物医学工程杂志》
CAS
2011年第3期277-279,共3页
Chinese Journal of Biomedical Engineering
参考文献19
-
1Falagas ME,Bliziotis IA.Pandrug-resistant Gram-negative bacterla:the dawn of the post-antibiotic era? Int J Antimicrob Agents,2007,29:630-636.
-
2王辉.非发酵糖革兰阴性杆菌感染的治疗困境与药物选择[J].中华结核和呼吸杂志,2008,31(10):728-730. 被引量:8
-
3Straatsma TP,Soares TA.Characterization of the outer membrane protein OprF of Pseudomonas aeruginosa in a lipopolysaccluaride membrane by computer simulation.Proteins,2009,74:475-488.
-
4Sugawara E,Nestorovich EM,Bezrukov SM,et al.Peeudomonas aeruginosa porin OprF exists in two different confornations.J Biol Chem,2006,281:16220-16229.
-
5Meyer JM.Exogenous siderophore-mediated iron uptake in Pseudomonas aeruginosa:possible involvement of porin OprF in iron translocation.J Gen Microbiol,1992,138:951-958.
-
6Azghani AO,Idell S,Bains M,et al.Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in culture.Microb Paibog,2002,33:109-114.
-
7Hughes EE,Gilleland LB,Gilleland HE Jr.Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P.aeruginosa.Infect Immun,1992,60:3497-3503.
-
8von Specht BU,Knapp B,Muth G,et al.Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P.aeruginosa outer membrane protein F and outer membrane protein Ⅰ fusion proteins.Infect Immun,1995,63:1855-1862.
-
9Worgall S,Krause A,Rivara M,et al.Protection against P.aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.J Clin Invest,2005,115:1281-1289.
-
10Peluso L,de Luca C,Bozza S,et al.Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.BMC Microbiol,2010,10:9.
二级参考文献29
-
1Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents ,2007,29 : 630-636.
-
2Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev, 2006, 19:637-657.
-
3Dubois V, Arpin C, Melon M, et al. Nosocomial outbreak due to a multiresistant strain of Pseudomonas aemginosa P12 : efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance. J Clin Microbiol,2001,39 : 2072-2078.
-
4Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis, 2003, 36:1111-1118.
-
5Linden PK, Kusne S, Coley K, et al. Use of parenteral colistin for the treatment of serious infection due to antimierobial-resistant Pseudomonas aeruginosa. Clin Infect Dis,2003, 37 :e154-e100.
-
6Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous colistin in the treatment of sepsis from multi-resistant Gram- negative bacilli in critically ill patients. Crit Care, 2003,7 : R78- R83.
-
7Sobieszczyk ME, Furuya EY, Hay CM, et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J Antimicrob Chemother ,2004,54 : 566-569.
-
8Michalapoulos A, Kasiakou SK, Mastora Z, et al. Aerosolized colistin for the treatment of nosocomial pneumonia due to mulidrug- resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care,2005,9 : R53-R59,
-
9Jaruratanasirikul S, Sriwiriyajan S, Punyo J. Comparison of the pharmacodynamics of meropenem in patients with ventilatorassociated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother,2005,49 : 1337- 1339.
-
10Souli M, Kontopidou FV, Koratzanis E, et al. In vitro activity of tigecycline against multi-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals. Antimicrob Agents Chemother, 2006, 50: 3166-3169.
共引文献15
-
1池琼,郑纪阳,戴新建,陈身贤,徐克.2005~2008年鲍氏不动杆菌的耐药性变迁分析[J].中华医院感染学杂志,2010,20(8):1163-1165. 被引量:19
-
2池琼,郑纪阳,戴新建,陈身贤,徐克.四年间鲍曼不动杆菌院内下呼吸道感染的临床分析[J].实用医学杂志,2010,26(10):1822-1824. 被引量:5
-
3徐峰倩.综合干预措施对控制医院常见多药耐药菌流行的影响[J].中华医院感染学杂志,2010,20(21):3279-3280. 被引量:4
-
4朱佑明,罗永艾.铜绿假单胞菌疫苗研究进展[J].中国人兽共患病学报,2010,26(12):1157-1159. 被引量:2
-
5杜娟,旷婧,肖显俊,龙启忠.重症监护病房耐亚胺培南非发酵菌医院获得性肺炎临床分析[J].中华医院感染学杂志,2011,21(11):2192-2195. 被引量:5
-
6高建钢,张永梅,福泉,张志敏,郭素芳,孟峻.铜绿假单胞菌的医院感染以及耐药性的变化[J].内蒙古医学院学报,2011,33(5):384-386.
-
7赵德,乔翠,张强,郭建宏,高凤山.表位疫苗研究进展[J].动物医学进展,2012,33(1):102-106. 被引量:6
-
8赵德,冯磊,张强,郭建宏,高凤山.表位疫苗的设计及应用研究进展[J].生命科学,2012,24(2):174-180. 被引量:7
-
9姜晓,谢茂超,余倩.评价铜绿假单胞菌结合疫苗免疫血清间接ELISA法的建立[J].现代预防医学,2012,39(23):6248-6250.
-
10姜明子,冯旰珠,邱文.铜绿假单胞菌重组核酸疫苗研究进展[J].中华传染病杂志,2013,31(10):630-634. 被引量:4
同被引文献17
-
1安蔚,赵苗青,李雅林,李松,康莉,宋文刚.含有非甲基化CpG的双歧杆菌DNA对小鼠骨髓树突状细胞成熟的影响[J].第四军医大学学报,2006,27(2):113-116. 被引量:2
-
2Gaynes R,E dwards JR.Overview of nosocomial infectionscaused bygram-negative bacilli[J].Clin Infect Dis,2005,41(6):848-854.
-
3D觟ring G,Pier GB.Vaccines and immunotherapy againstPseudomonas aeruginosa[J].Vaccine,2008,26(8):1011-1024.
-
4Worgall S,Krause A,Rivara M,et al.Protection againstPseudomonas aeruginosa with an adenovirus vector containingan OprF epitope in the capsid[J].J clin Invest,2005,115(5):1281-1289.
-
5Peluso L,de Luca C,Bozza S,et al.Protection againstPseudomonas aeruginosa lung infection in mice byrecombinant OprF-pulsed dendritic cell immunization[J].BMC Microbiology,2010,10:9.
-
6Krause A,Whu WZ,Xu Y,et al.Protective anti-Pseudomonasaeruginosa humoral and cellular mucosal immunity byAdC7-mediated expression of the P.aeruginosa proteinOprF[J].Vaccine,2011,29(11):2131-2139.
-
7Hartl D,Griese M,Kappler M,et al.Pulmonary T(H)2response in Pseudomonas aeruginosa infected patients withcystic fibrosis[J].J Allergy Clin Immunol,2006,117(1):204-211.
-
8Belkaid Y.Regulatory T cells and infection:a dangerousnecessity[J].Nat Rev Immunol,2007,7(11):875-888.
-
9Bumann D,Behre C,Behre K,et al.Systemic,nasal and orallive vaccines against Pseudomonas aeruginosa:a clinicaltrial of immunogenicity in lower airways of human volunteers[J].Vaccine,2010,28(3):707-713.
-
10Kamei A,Coutinho Sledge YS,Goldberg JB,et al.Mucosalvaccination with a multivalent,live-attenuated vaccineinduces multifactorial immunity against Pseudomonasaeruginosa acute lung infection[J].Infect Immun,2011,79(3):1289-1299.
二级引证文献8
-
1姜明子,冯旰珠,邱文.铜绿假单胞菌重组核酸疫苗研究进展[J].中华传染病杂志,2013,31(10):630-634. 被引量:4
-
2刘美辰,贺莉芳,周必英.重组双歧杆菌研究进展[J].中国病原生物学杂志,2014,9(5):470-472. 被引量:10
-
3李文桂,陈雅棠.载体介导的铜绿假单胞菌OprF疫苗的研制现状[J].中国病原生物学杂志,2016,11(5):476-479. 被引量:4
-
4李文桂,陈雅棠.铜绿假单胞菌OprF疫苗的研究进展[J].热带医学杂志,2016,16(11):1468-1472. 被引量:2
-
5刘潇,李文桂.两歧双歧杆菌介导的铜绿假单胞菌外膜蛋白Ⅰ(Bb-OprⅠ)疫苗免疫增强小鼠对铜绿假单胞菌的抑制作用[J].细胞与分子免疫学杂志,2017,33(8):1040-1044. 被引量:3
-
6刘潇,李文桂.铜绿假单胞菌重组Bb-OprI疫苗诱导小鼠保护力和脾细胞因子基因表达变化的研究[J].中国病原生物学杂志,2018,13(3):226-229. 被引量:6
-
7江帆,李文桂.铜绿假单胞菌重组Bb-OprH疫苗诱导的保护力及其细胞免疫应答[J].分子影像学杂志,2019,42(1):63-66.
-
8梁诚诚,李文桂.重组Bb(pGEX-OprF-I)疫苗的构建及对小鼠的诱导保护作用[J].细胞与分子免疫学杂志,2019,35(7):589-594. 被引量:3
-
1曹瑞华,温海.新生隐球菌磷脂酶的研究进展[J].国外医学(皮肤性病学分册),2002,28(5):297-300. 被引量:2
-
2王春霞,李永伟,贺文生.42株催娩克雷伯菌的鉴定分析与药敏实验[J].河南诊断与治疗杂志,2001,15(2):80-80.
-
3黄阿莉,王宏颖.233株鲍曼不动杆菌对抗生素的耐药性分析[J].中国实验诊断学,2011,15(11):1963-1964. 被引量:1
-
4徐修礼,樊新,孙怡群,刘家云,郝晓柯.鲍曼不动杆菌的泵出机制及抗菌药物的联合应用[J].中国药物与临床,2008,8(9):743-744. 被引量:5
-
5尹金玲,满其航,崔玉芳,杜丽,马琼.微波辐照诱发Wistar大鼠外周血淋巴细胞亚群变化[J].辐射防护通讯,2011,31(4):19-22. 被引量:2
-
6王涛,陈建平.军团菌致病机制研究进展[J].中国人兽共患病杂志,2004,20(7):645-648. 被引量:8
-
7董国苗.医护人员艾滋病职业暴露风险的干预策略[J].实用医技杂志,2011,18(9):942-943. 被引量:4
-
8顾菊林.新型隐球菌的毒性因子[J].国外医学(微生物学分册),1996,19(4):29-32. 被引量:4
-
9韩芳,丁昌平,顾军,童建东,张敏,汪竹,张正荣,汪瑞,曹春梅,柳健.肺癌患者CD4^+ CD25^+调节性T细胞的检测及临床意义[J].放射免疫学杂志,2008,21(1):77-79. 被引量:2
-
10黄作平,高兴林.免疫细胞在阻塞性睡眠呼吸暂停低通气综合征中的作用[J].国际呼吸杂志,2006,26(6):425-427. 被引量:3